NCT00001644View on ClinicalTrials.gov

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 3, 1997

Primary Completion Date

February 17, 2010

Study Completion Date

February 17, 2010

Conditions
HIV Infection
Interventions
DRUG

Indinavir

DRUG

Zidovudine

DRUG

Lamivudine

DRUG

Nevirapine

PROCEDURE

Blood testing

PROCEDURE

Lymph node biospy

PROCEDURE

Leukapheresis

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH